Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Season and city shape urban bioaerosol composition beyond vegetation and socioeconomic gradients.

The Science of the total environment·2026
Same author

Reproductive toxicity of emerging plasticizers, flame retardants, and bisphenols, using culture of the rat fetal testis†.

Biology of reproduction·2023
Same author

Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.

PloS one·2022
Same author

Cellular senescence limits translational readthrough.

Biology open·2021
Same author

Methodological considerations when establishing reliable and valid normative data: Canadian Longitudinal Study on Aging (CLSA) neuropsychological battery.

The Clinical neuropsychologist·2021
Same author

Altered Theory of Mind in Parkinson's Disease and Impact on Caregivers: A Pilot Study.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2021
Same journal

Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer's Disease.

International journal of Alzheimer's disease·2024
Same journal

Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review.

International journal of Alzheimer's disease·2024
Same journal

Novel Biomarkers for Alzheimer's Disease: Plasma Neurofilament Light and Cerebrospinal Fluid.

International journal of Alzheimer's disease·2024
Same journal

<i>In Silico</i> Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer's Diseases.

International journal of Alzheimer's disease·2024
Same journal

Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer's Disease: Insights from Computational Studies.

International journal of Alzheimer's disease·2023
Same journal

Prognosis of Biomarker of Alzheimer's Disease in the Function of the Retina and Secondary Molecular Structure Variation of the Retina and Brain.

International journal of Alzheimer's disease·2023
See all related articles

Related Experiment Video

Updated: May 29, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Cognitive stimulation programs in healthy elderly: a review.

Sarah Tardif1, Martine Simard

  • 1École de Psychologie, Université Laval Pavillon Félix-Antoine Savard, 2325 rue des Bibliothèques, local 1116, Québec, QC, Canada G1V 0A6.

International Journal of Alzheimer'S Disease
|August 31, 2011
PubMed
Summary
This summary is machine-generated.

Cognitive interventions show promise for improving cognitive function in healthy older adults. This review of 14 studies suggests memory training is common, with various techniques yielding positive results.

More Related Videos

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Related Experiment Videos

Last Updated: May 29, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Area of Science:

  • Gerontology
  • Cognitive Psychology
  • Neuroscience

Background:

  • Aging is associated with cognitive changes, prompting interest in interventions for healthy older adults.
  • Community-based settings are common for administering cognitive programs to the elderly.
  • Memory is a primary target for many cognitive training and stimulation programs.

Purpose of the Study:

  • To investigate the efficacy of cognitive intervention programs for healthy elderly individuals.
  • To synthesize findings from 14 distinct cognitive intervention studies.
  • To propose recommendations for enhancing future cognitive interventions.

Main Methods:

  • Systematic literature search of PsycINFO and PubMed databases.
  • Inclusion of 14 studies on cognitive interventions for healthy older adults.
  • Analysis of cognitive techniques (e.g., memory strategies) and outcome measures.

Main Results:

  • All 14 studies reported improvements in at least one outcome measure.
  • Memory was the focus in 9 out of 14 studies.
  • Techniques included face-name associations, mental imagery, and method of loci.

Conclusions:

  • Cognitive interventions can lead to positive outcomes in healthy older adults.
  • Future research should employ robust designs and assess real-world generalization.
  • Assessing quality of life and daily living activities is recommended.